New genetic variants could raise a woman’s risk of cervical cancer from HPV infections

Human papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each year worldwide.

The FDA Issues Guidance on Designing Psychedelic Clinical Trials | Psychedelic Spotlight

On June 23rd of this year, the U.S. Food and Drug Administration published a new draft guidance intended to advise researchers on study design when

June 27, 2023

Reunion Neuroscience Inc. and MPM BioImpact Announce Completion of Plan of Arrangement | Psychedelic Invest

Reunion Neuroscience Inc. (TSX: REUN / NASDAQ: REUN), a clinical-stage biopharmaceutical company committed to developing innovative and patented therapeutic solutions for underserved mental health conditions

August 3, 2023

Study sheds light on how SARS-CoV-2 virus switches between replication and packaging

Immediately after the infection of a cell in the throat or lungs, the SARS-CoV-2 virus works very hard to replicate, using the human cell’s metabolic

August 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.